Table 1 The characteristics of the patients in the LVI-negative and LVI-positive groups

Maximum diameter (cm)

2.89 ± 1.12

3.09 ± 1.18

0.312^b

1.16 (0.86–1.55)

0.312

Minimum diameter (cm)

1.85 ± 0.65

1.92 ± 0.72

0.528^b

1.17 (0.70–1.92)

0.526

ER

0.837^a

Negative

50 (34.25%)

14 (32.56%)

1

NA

Positive

96 (65.75%)

29 (67.44%)

1.08 (0.53–2.27)

0.837

PR

0.523^a

Negative

70 (47.95%)

23 (53.49%)

1

NA

Positive

76 (52.05%)

20 (46.51%)

0.80 (0.40–1.58)

0.523

HER2

0.845^a

Negative

103 (70.55%)

31 (72.09%)

1

NA

Positive

43 (29.45%)

12 (27.91%)

0.93 (0.42–1.94)

0.845

Ki-67

0.409^a

≤20%

47 (32.19%)

11 (25.58%)

1

NA

>20%

99 (67.81%)

32 (74.42%)

1.38 (0.66–3.08)

0.410

T stage

0.109^c

T0

14 (9.59%)

0 (0.00%)

0.0 (0.0-3.48 × 10 ¹³)

0.988

T1

46 (31.51%)

10 (23.26%)

1

NA

T2

84 (57.53%)

32 (74.42%)

1.75 (0.81–4.05)

0.167

T3

1 (0.68%)

0 (0.00%)

0.0 (NA-Inf)

0.997

T4

1 (0.68%)

1 (2.33%)

4.6 (0.17–123.2)

0.295

 N stage

0.003 ^c

N0

91 (62.33%)

17 (39.53%)

1

NA

N1

40 (27.40%)

15 (34.88%)

2.01 (0.91–4.43)

0.083

N2

10 (6.85%)

7 (16.28%)

3.75 (1.21–11.2)

0.018

N3

5 (3.42%)

4 (9.30%)

4.28 (0.98–17.85)

0.044

Parameters

K^trans(min^− 1)

0.21 ± 0.11

0.22 ± 0.12

0.766^b

1.58 (0.07–30.11)

0.765

K_ep(min^− 1)

0.81 ± 0.23

0.92 ± 0.30

0.012 ^b

5.52 (1.42–23.3)

0.016

V _e

0.27 ± 0.13

0.24 ± 0.09

0.102^b

0.12 (0.01–2.15)

0.163

 W-in (min^− 1)

0.56 ± 0.22

0.61 ± 0.24

0.228^b

2.50 (0.56–11.17)

0.228

 W-out (min^− 1)

-0.01 ± 0.02

-0.02 ± 0.02

0.088^b

0.00 (0.0-9.35)

0.090

TTP (min)

0.69 ± 0.21

0.64 ± 0.17

0.165^b

0.25 (0.03–1.58)

0.167